2717 related articles for article (PubMed ID: 9357492)
1. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
2. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor-beta modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells.
Cao L; Bu R; Oakley JI; Kalla SE; Blair HC
J Cell Biochem; 2003 May; 89(1):152-64. PubMed ID: 12682916
[TBL] [Abstract][Full Text] [Related]
4. The effects of triiodothyronine on human osteoblast-like cells metabolism and interactions with growth hormone.
Pepene CE; Seck T; Pfeilschifter J; Gozariu L; Ziegler R; Kasperk CH
Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):66-72. PubMed ID: 12746755
[TBL] [Abstract][Full Text] [Related]
5. Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4.
Kassem M; Okazaki R; De León D; Harris SA; Robinson JA; Spelsberg TC; Conover CA; Riggs BL
Proc Assoc Am Physicians; 1996 Mar; 108(2):155-64. PubMed ID: 8705735
[TBL] [Abstract][Full Text] [Related]
6. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
Kassem M; Brixen K; Blum WF; Mosekilde L; Eriksen EF
J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819
[TBL] [Abstract][Full Text] [Related]
7. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
[TBL] [Abstract][Full Text] [Related]
8. Growth factors and bone formation in osteoporosis: roles for IGF-I and TGF-beta.
Marie P
Rev Rhum Engl Ed; 1997 Jan; 64(1):44-53. PubMed ID: 9051859
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
[TBL] [Abstract][Full Text] [Related]
11. Stimulatory effect of insulin-like growth factor binding protein-5 on mouse osteoclast formation and osteoclastic bone-resorbing activity.
Kanatani M; Sugimoto T; Nishiyama K; Chihara K
J Bone Miner Res; 2000 May; 15(5):902-10. PubMed ID: 10804020
[TBL] [Abstract][Full Text] [Related]
12. Bone cell responsiveness to transforming growth factor beta, parathyroid hormone, and prostaglandin E2 in normal and postmenopausal osteoporotic women.
Lomri A; Marie PJ
J Bone Miner Res; 1990 Nov; 5(11):1149-55. PubMed ID: 2176773
[TBL] [Abstract][Full Text] [Related]
13. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures.
Ramalho AC; Couttet P; Baudoin C; Morieux C; Graulet AM; de Vernejoul MC; Cohen-Solal ME
Eur Cytokine Netw; 2002; 13(1):39-45. PubMed ID: 11956019
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation.
Fromigué O; Marie PJ; Lomri A
J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro.
Marie PJ; De Vernejoul MC; Lomri A
J Bone Miner Res; 1992 Jan; 7(1):103-13. PubMed ID: 1549953
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1.
Abdallah BM; Jensen CH; Gutierrez G; Leslie RG; Jensen TG; Kassem M
J Bone Miner Res; 2004 May; 19(5):841-52. PubMed ID: 15068508
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone stimulates proliferation of normal human bone marrow stromal osteoblast precursor cells in vitro.
Kassem M; Mosekilde L; Eriksen EF
Growth Regul; 1994 Sep; 4(3):131-5. PubMed ID: 7858486
[TBL] [Abstract][Full Text] [Related]
18. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M
Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells.
Scheven BA; Hamilton NJ; Fakkeldij TM; Duursma SA
Growth Regul; 1991 Dec; 1(4):160-7. PubMed ID: 1842348
[TBL] [Abstract][Full Text] [Related]
20. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.
Scheven BA; van der Veen MJ; Damen CA; Lafeber FP; Van Rijn HJ; Bijlsma JW; Duursma SA
J Bone Miner Res; 1995 Jun; 10(6):874-80. PubMed ID: 7572311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
